The development of more complex, biologically relevant, and predictive cell-based assays for compound screening is a primary challenge in drug discovery. The integration of three-dimensional (3D) assay models is becoming more widespread to drive translational biology. Higher complexity cell models have gained popularity because they better mimic in vivo environments and responses to drug treatment. However, a large adoption of 3D cell models is still hampered by heterogeneity in culture protocols and the lack of suitable analytic technologies; results in 3D can be controversial and difficult to interpret. Celldynamics believes that 3D Biology is the future of life sciences and works developing technological solutions to cover the lack of standardization, quality control, and diagnostic purposes for 3D cellular models.
CellDynamics
Via Villa Clelia
62/D
Imola, Emilia-Romagna 40026
Italy